Lv5
1370 积分 2024-01-26 加入
Efficacy and Safety of Tezepelumab in Adults With Severe, Uncontrolled Asthma in Asia: Results From the Phase 3 DIRECTION Study
1个月前
已完结
Anaphylaxis: A 2023 practice parameter update
2个月前
已完结
Safety, tolerability and efficacy of repeated intravenous infusions of KHK4083, a fully human anti-OX40 monoclonal antibody, in Japanese patients with moderate to severe atopic dermatitis
2个月前
已完结
An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b study
2个月前
已完结
Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial
3个月前
已完结
Safety and Efficacy of Dexpramipexole in Eosinophilic Asthma (EXHALE): A randomized controlled trial
3个月前
已完结
Sepsis and septic shock
3个月前
已完结
IL-33/ST2 axis in autoimmune disease
4个月前
已完结
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study
8个月前
已完结
Robust meta‐analytic‐predictive priors in clinical trials with historical control information
9个月前
已完结
皖公网安备34019202002308
